The safety label of the antibiotic Levaquin has been updated to include new warnings involving the risk of suicidality, according to a Food and Drug Administration (FDA) Safety Label Changes update. Levaquin, known generically as levofloxacin, is in a class of drugs called fluoroquinolones, which are known to increase the risk of central nervous system effects including convulsions and toxic psychoses, and may cause central nervous system stimulation which may lead to anxiety, tremors, restlessness, lightheadedness, hallucinations, paranoia, depression, nightmares, insomnia, and suicidal thoughts. The labels have been updated to include the risk for attempted suicide and completed suicide, “especially ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.